Funder: National Institutes of Health
Due Dates: April 4, 2025 | October 3, 2025 | December 9, 2025 (current closing date)
Funding Amounts: Up to $150,000/year (direct costs) | Max project period: 3 years | Estimated 4 awards | Total program funding: $1,000,000
Summary: Supports early-stage, high-risk/high-impact technology development to improve the quality and handling of biospecimens for cancer research and clinical care.
Key Information: Clinical trials are not allowed; applications must focus on technical innovation, not biological hypotheses.